PPA
MBIO icon

Parametric Portfolio Associates’s Mustang Bio MBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-79
Closed -$99K – 3728
2021
Q4 		$99K Buy
79
+54
+216% +$87.2K ﹤0.01% 3550
2021
Q3 		$50K Buy
25
+11
+79% +$23.6K ﹤0.01% 3574
2021
Q2 		$36K Sell
14
-5
-26% -$12.3K ﹤0.01% 3550
2021
Q1 		$46K Buy
19
+2
+12% +$5.95K ﹤0.01% 4028
2020
Q4 		$48K Buy
17
+1
+6% +$2.39K ﹤0.01% 3949
2020
Q3 		$37K Sell
16
-4
-20% -$9.86K ﹤0.01% 3888
2020
Q2 		$47K Buy
20
+1
+5% +$2.34K ﹤0.01% 3870
2020
Q1 		$38K Sell
19
-6
-24% -$15.4K ﹤0.01% 3861
2019
Q4 		$75K Sell
25
-1
-4% -$2.29K ﹤0.01% 3896
2019
Q3 		$64K Sell
26
-10
-28% -$27.4K ﹤0.01% 3887
2019
Q2 		$99K Buy
36
+13
+57% +$37.1K ﹤0.01% 3844
2019
Q1 		$59K Buy
23
+1
+5% +$2.83K ﹤0.01% 3871
2018
Q4 		$48K Sell
22
-5
-19% -$15.2K ﹤0.01% 3854
2018
Q3 		$119K Sell
27
-6
-18% -$30K ﹤0.01% 3829
2018
Q2 		$173K Buy
+33
New +$208K ﹤0.01% 3722

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parametric Portfolio Associates's MBIO Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Mustang Bio (MBIO) in Q1 2022, closing a stake of 79 shares — an estimated $99K sold.

Parametric Portfolio Associates first reported a position in MBIO in Q2 2018 and held it in 15 quarters. The position peaked at $173K in Q2 2018. 81 funds tracked by Wall St. Rank hold MBIO as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Mustang Bio position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 79 Mustang Bio shares in Q1 2022, an estimated $99K.
  • Parametric Portfolio Associates first reported a position in Mustang Bio in Q2 2018 and held it in 15 quarters.
  • Parametric Portfolio Associates's Mustang Bio position peaked at $173K in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.